Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality

BACKGROUND: The addition of annual MRI screening to mammography has heightened optimism that intensive screening along with improved treatments may substantially improve life expectancy of women at high risk of breast cancer. However, survival data from BRCA2 mutation carriers undergoing intensive c...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, D. G., Harkness, E. F., Howell, A., Wilson, M., Hurley, E., Holmen, M. M., Tharmaratnam, K. U., Hagen, A. I., Lim, Y., Maxwell, A. J., Moller, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832454/
https://www.ncbi.nlm.nih.gov/pubmed/27087880
http://dx.doi.org/10.1186/s13053-016-0048-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832454/
https://www.ncbi.nlm.nih.gov/pubmed/27087880
http://dx.doi.org/10.1186/s13053-016-0048-3

Ejemplares similares